BlackRock Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.18M | Buy |
14,797
+5,055
| +52% | +$401K | ﹤0.01% | 2043 |
|
|
2016
Q3 | $682K | Buy |
9,742
+6,872
| +239% | +$481K | ﹤0.01% | 2189 |
|
|
2016
Q2 | $111K | Sell |
2,870
-46
| -2% | -$1.78K | ﹤0.01% | 2757 |
|
|
2016
Q1 | $118K | Buy |
2,916
+1,126
| +63% | +$45.6K | ﹤0.01% | 2696 |
|
|
2015
Q4 | $159K | Sell |
1,790
-1,938
| -52% | -$172K | ﹤0.01% | 2564 |
|
|
2015
Q3 | $276K | Sell |
3,728
-5,411
| -59% | -$401K | ﹤0.01% | 2411 |
|
|
2015
Q2 | $739K | Buy |
+9,139
| New | +$739K | ﹤0.01% | 2097 |
|